import React from 'react';

import PageContainer from '../../../components/pagecontainer/index';
import MainContent from '../../../components/maincontent';
// import ConnectionModal from '../../../components/modals/ConnectionModal';
import mapImage from '../../../assets/common/access.png';
// import connectionIcon from '../../../assets/atoms/connection-icon-red.png';

const navOptions = [
  {
    id: 0,
    level: 3,
    title: 'Overview',
    activeMenu: 2,
    parentTitle: 'Rapid Access to Personalised Interventions',
    parentLink: '/phc/future-patient-journey',
    link: '/phc/future-patient-journey/access/overview',
    active: false,
  },
  {
    id: 1,
    level: 3,
    title: 'Diagnostics',
    activeMenu: 2,
    parentTitle: 'Rapid Access to Personalised Interventions',
    parentLink: '/phc/future-patient-journey',
    link: '/phc/future-patient-journey/access/diagnostics',
    active: true,
  },
  {
    id: 2,
    level: 3,
    title: 'CDS Systems',
    activeMenu: 2,
    parentTitle: 'Rapid Access to Personalised Interventions',
    parentLink: '/phc/future-patient-journey',
    link: '/phc/future-patient-journey/access/cds-systems',
    active: false,
  },
  {
    id: 3,
    level: 3,
    title: 'Digital Health (SaMD)',
    activeMenu: 2,
    parentTitle: 'Rapid Access to Personalised Interventions',
    parentLink: '/phc/future-patient-journey',
    link: '/phc/future-patient-journey/access/digital-health',
    active: false,
  },
  {
    id: 4,
    level: 3,
    title: 'Value-based Healthcare',
    activeMenu: 2,
    parentTitle: 'Rapid Access to Personalised Interventions',
    parentLink: '/phc/future-patient-journey',
    link: '/phc/future-patient-journey/access/value-based-healthcare',
    active: false,
  },
];

function AccessDiagnostics() {
//   const [connectionOpen, setConnectionOpen] = useState(false);
//
//   const openConnectionModal = () => {
//     setConnectionOpen(true);
//   };
//
//   const handleCloseClick = () => {
//     setConnectionOpen(false);
//   };
//
//   const mainContent = (
//     <>
//       <h2>Description</h2>
//       <p>
//         Diagnostic tools are used to detect diseases or other conditions, and can be used to monitor a
//         person’s overall health to help cure, treat, or prevent diseases. Moreover, they may support
//         precision medicine to identify patients who are likely to benefit from specific treatments or therapies.
//         <br />
//         Roche is a pioneer and leader in diagnostics, including many technologies in common clinical practice
//         today. Ensuring that patients have access to the right diagnostic at the right time at initial
//         diagnosis, monitoring, and at recurrence or progression is a core element of the changes we are
//         driving with personalised healthcare (PHC).
//       </p>
//       <h2>Why it is important for PHC</h2>
//       <span>
//         <strong>Smarter and more efficient R&D</strong>
//         <br />
//                 To support Roche’s PHC efforts, our diagnostics tool offering is evolving as do the diagnostic
//                 technology. We are invested in developing PHC-enabling diagnostic tools, such as:
//         <li>
//           <strong>Companion diagnostics</strong>
//           {' '}
//           (CDx) help healthcare professionals determine whether a
//                 particular
//                 therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.
//         </li>
//         <li>
//           <strong>Complementary diagnostics</strong>
//           {' '}
//           inform treatment decisions. They help give healthcare
//                 professionals
//                 a better picture of a patient’s overall prognosis or likelihood to respond to different therapies.
//         </li>
//         <li>
//           <strong>Predictive diagnostics</strong>
//           {' '}
//           provide information about how patients may respond to a
//                 specific target or therapy.
//         </li>
//       </span>
//       <p>
//         <strong>Improved access & personalized care</strong>
//         <br />
//       </p>
//       <span>
//         <strong>What it means for patients</strong>
//         <br />
//               Roche diagnostic tools support:
//         <li>
//                 Selection of the most appropriate patient treatment group
//         </li>
//         <li>
//                 Minimization of sides effects
//         </li>
//         <li>
//                 Maximization of efficacy.
//         </li>
//         <span>
// Roche makes these diagnostics available to more patients faster through its commercial
//                   expertise and unmatched global reach.
//         </span>
//       </span>
//       <p>
//         <strong>What it means for health systems</strong>
//         <br />
//         Roche diagnostic tools that help to improve medical decision making may increase the
//         speed and rate of funding for our therapies.
//       </p>
//       <strong className="d-none d-md-block d-sm-none">Click button below to see:</strong>
//       <div className="connection-button d-flex align-items-center" onClick={openConnectionModal}>
//         <img src={connectionIcon} alt="connection icon" />
//         Connections with Other PHC Topics
//       </div>
//       <div className="diagnosis-second-section" />
//       <h2>
//         What Roche is doing in this area
//       </h2>
//       <p>
//         Roche pioneered the use of CDx with the launch of HER2 for the Roche cancer drug Herceptin. Today,
//         Roche Tissue Diagnostics is
//         the
//         {' '}
//         <strong>
//           global partner of choice for CDx, collaborating with more
//           than 30 additional pharmaceutical companies
//         </strong>
//         {' '}
//         to investigate and develop innovative
//         predictive diagnostics identifying those patients who are more likely to respond to specific therapies.
//       </p>
//       <h2>Key drivers/considerations</h2>
//       <li>
//         Fast turnaround time for results could be a driver of diagnostics adoption
//       </li>
//       <li>
//         Successful identification of patients candidate to a targeted Roche medication depends on use of
//         appropriate and high-quality testing. Rozlytrek diagnostics strategy is an example of PHC in action.
//         It aims at establishing molecular profiling as part of the standard of care, so that many patients
//         have the chance to benefit from Rozlytrek.
//         [link to press release
//         press release
//         {' '}
//         <a href="https://www.roche.com/media/releases/med-cor-2019-08-16.htm ">
//           https://www.roche.com/media/releases/med-cor-2019-08-16.htm
//         </a>
//         {' '}
//         and internal hyperlink to page about Rozlytrek.]
//       </li>
//       <li>
//         Level of funding of advanced diagnostics by the healthcare system as diagnostic tool may greatly
//         varies across countries and regions
//       </li>
//     </>
//   );

  const mainContent = (
    <h1 className="text-center">
      Content Coming Soon
    </h1>
  );

  const content = (
    <div className="access-diagnostics page-wrapper d-flex align-items-center justify-content-center">
      <div className="detail-map">
        <img src={mapImage} alt="detail map" />
      </div>
      {/* <ConnectionModal open={connectionOpen} handleCloseClick={handleCloseClick} /> */}
      <MainContent content={mainContent} navOptions={navOptions} />
    </div>
  );

  return (
    <PageContainer
      page={content}
      navOptions={navOptions}
      title="Rapid Access to Personalised Interventions"
      color="blue"
    />
  );
}

export default AccessDiagnostics;
